Drug Type Small molecule drug |
Synonyms Docebenone (USAN/INN), A 61589, A-61589 + [2] |
Target |
Action inhibitors |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H26O3 |
InChIKeyWDEABJKSGGRCQA-UHFFFAOYSA-N |
CAS Registry80809-81-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D03882 | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 2 | United States | - | - |
| Asthma | Phase 2 | Japan | - | |
| Asthma | Phase 2 | Canada | - | - |
| Asthma | Phase 2 | Puerto Rico | - | - |
| Rhinitis, Allergic | Phase 2 | United States | - | - |
| Rhinitis, Allergic | Phase 2 | Japan | - | |
| Rhinitis, Allergic | Phase 2 | Canada | - | - |
| Rhinitis, Allergic | Phase 2 | Puerto Rico | - | - |
| Neoplasms | Preclinical | Sweden | - | - |
| Stomach Diseases | Preclinical | Japan | - |





